Back to calendar
Contineum Therapeutics, Inc. (CTNM) Earnings
CTNM reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.45
Actual EPS: $-0.40
EPS surprise: 10.87%
Company overview
Market Cap$579.1M
PriceUSD 15.49
EPS (TTM)-1.74
52-week high16.91
52-week low5.71
SectorHealth Technology
IndustryBiotechnology
Employees51